Amarin Corp Plc (AMRN)

[JRoon71]

Great points, Zip.

I think these are the most critical for a buyer:

-Potential buyers are waiting to see more European approvals for the sale of Vascepa
-Buyers want to know about what European National Health Services will be willing to pay for Vascepa
-The same holds true for China

From a risk perspective, I think they need to know that the "Big 3" in Europe will approve and reimburse, and at a reasonable price. Because once those prices are locked in, that's pretty much it. Without them, Europe revenue is dead. And Italy, France, and Germany represent a huge portion of EU revenue. Those three represent nearly half of the EU population (and is about 2/3 the size of the U.S.).

Germany, UK, Italy, France, and Spain = U.S. population